Measure the impact of treatments on the microbiome
The microbiome’s central role in health makes it an important system to examine in the development and testing of new therapies.
With highly accurate metagenomic analysis of the microbiome throughout your trial, you can be confident about the safety and impact of your therapy at each stage of development and testing. Microba enables streamlined assessment of your microbiome endpoints.Discuss your project
- End-to-end microbiome clinical trial support
- Expert consultation and advice
- Measure microbiome changes after intervention
- Discover response and stratification biomarkers
- Uncover mechanisms of action
Evaluate how the microbiome responds
Track strains of interestHigh-resolution identification of strains to reveal microbial therapeutic persistence and clearance, or target strain elimination.
Reveal functional insightsGenes and pathways revealed by genome-based metagenomic profiling leveraging a comprehensive reference genome database.
High accuracy profilingLeading bioinformatic tools for community profiling, ensuring a low number of false positives for robust results.
Optimised workflows for reliable resultsEvery step, from sample collection and processing to bioinformatics and statistics, is optimised for accurate and reliable results.
Lab with international accreditationSample processing and data generation in a highly-automated, single-process laboratory with GLP/GCP standards and ISO15189 accreditation.
Bespoke analysis & results interpretationDraw on our deep understanding of the composition and function of the gut microbiome for support with data analysis and interpretation.